(Q34181975)

31 July 2017

1 reference

title

Tumour necrosis factor-alpha blockade: a new era for effective management of rheumatoid arthritis (English)

1 reference

31 July 2017

0 references

1 reference

2

Clair EW

1 reference

31 July 2017

Hamilton K

1

1 reference

PubMed ID

11249494

31 July 2017

language of work or name

English

0 references

publication date

1 July 2000

1 reference

Expert Opinion on Pharmacotherapy

31 July 2017

1 reference

31 July 2017

1

1 reference

31 July 2017

5

1 reference

31 July 2017

1041-1052

1 reference

The costs of rheumatoid arthritis

31 July 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1041

Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1041

Combination therapy with multiple disease-modifying antirheumatic drugs in rheumatoid arthritis: a preventive strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1041

Pathogenesis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1041

Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1041

Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1041

Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1041

Immunoregulatory role of interleukin 10 in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1041

Modulation of proinflammatory cytokine production in tumour necrosis factor-alpha (TNF-alpha)-transgenic mice by treatment with cells engineered to secrete IL-4, IL-10 or IL-13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1041

Inhibition of ligand binding and antiproliferative effects of tumor necrosis factor and lymphotoxin by soluble forms of recombinant P60 and P80 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1041

Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1041

A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1041

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1041

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1041

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1041

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1041

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1041

Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1041

The clinical and health status of patients with recent-onset rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1041

Combination Therapy with Cyclosporine and Methotrexate in Severe Rheumatoid Arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.1041

10.1517/14656566.1.5.1041

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11249494